Skip to main content
. 2024 Feb 16;14:3900. doi: 10.1038/s41598-024-53499-x

Table 2.

Gene Ontology (GO) enrichment analysis of target genes predicted for differentially expressed miRNAs (padjusted < 0.05, log2FC ≥ 1.0/log2FC ≤  − 1.0) in mare endometrium samples obtained during pre-attachment period of pregnancy (day 26–28).

No GO term ID Term name Term category padjusted Number of miRNA target genes enriched to GO term Number of miRNA target genes enriched to particular GO term List of miRNA target genes enriched to the particular GO term
1 GO:0015276 Ligand-gated ion channel activity Molecular function 0.00421618620809567 787 16 CHRNA6, CHRNB3, KCNJ16, ASIC2, KCNJ13, GABRE, GABRG1, GLRA4, HTR3A, GABRB3, GLRA1, KCNJ5, ASIC3, CFTR, CHRND, CHRNA1
2 GO:0022834 Ligand-gated channel activity molecular function 0.00421618620809567 787 16 CHRNA6, CHRNB3, KCNJ16, ASIC2, KCNJ13, GABRE, GABRG1, GLRA4, HTR3A, GABRB3, GLRA1, KCNJ5, ASIC3, CFTR, CHRND, CHRNA1
3 GO:0022824 Transmitter-gated ion channel activity Molecular function 0.0281591760051717 787 10 CHRNA6, CHRNB3, GABRE, GABRG1, GLRA4, HTR3A, GABRB3, GLRA1, CHRND, CHRNA1
4 GO:0022835 Transmitter-gated channel activity Molecular function 0.0281591760051717 787 10 CHRNA6, CHRNB3, GABRE, GABRG1, GLRA4, HTR3A, GABRB3, GLRA1, CHRND, CHRNA1
5 GO:0022836 Gated channel activity Molecular function 0.0422960252917783 787 23 CHRNA6, CHRNB3, VDAC3, KCNJ16, CACNB1, ASIC2, KCNJ13, GABRE, GABRG1, GLRA4, CACNG7, KCNV2, TMEM150C, HTR3A, GABRB3, GLRA1, SNAP25, KCNJ5, KCNC4, ASIC3, CFTR, CHRND, CHRNA1
6 GO:0098960 Postsynaptic neurotransmitter receptor activity Molecular function 0.0422960252917783 787 8 CHRNA6, CHRNB3, CHRM1, GABRG1, GABRB3, GLRA1, CHRND, CHRNA1
7 GO:0099529 Neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential Molecular function 0.0422960252917783 787 8 CHRNA6, CHRNB3, CHRM1, GABRG1, GABRB3, GLRA1, CHRND, CHRNA1
8 GO:0099094 Ligand-gated cation channel activity molecular function 0.0422960252917783 787 10 CHRNA6, CHRNB3, KCNJ16, ASIC2, KCNJ13, HTR3A, KCNJ5, ASIC3, CHRND, CHRNA1